Alpha Tau Medical Ltd. (DRTS)
Total Valuation
DRTS has a market cap or net worth of $205.53 million. The enterprise value is $137.02 million.
Market Cap | 205.53M |
Enterprise Value | 137.02M |
Important Dates
The last earnings date was Thursday, March 7, 2024, after market close.
Earnings Date | Mar 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DRTS has 69.67 million shares outstanding. The number of shares has increased by 9.20% in one year.
Shares Outstanding | 69.67M |
Shares Change (YoY) | +9.20% |
Shares Change (QoQ) | +0.21% |
Owned by Insiders (%) | 25.72% |
Owned by Institutions (%) | 2.74% |
Float | 51.74M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.43 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.08, with a Debt / Equity ratio of 0.16.
Current Ratio | 12.08 |
Quick Ratio | n/a |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.46 |
Financial Efficiency
Return on equity (ROE) is -31.90% and return on invested capital (ROIC) is -36.50%.
Return on Equity (ROE) | -31.90% |
Return on Assets (ROA) | -26.40% |
Return on Capital (ROIC) | -36.50% |
Revenue Per Employee | n/a |
Profits Per Employee | -$240,967 |
Employee Count | 121 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, DRTS has paid $16,000 in taxes.
Income Tax | 16,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.24% in the last 52 weeks. The beta is 0.71, so DRTS's price volatility has been lower than the market average.
Beta (1Y) | 0.71 |
52-Week Price Change | +4.24% |
50-Day Moving Average | 3.06 |
200-Day Moving Average | 3.37 |
Relative Strength Index (RSI) | 47.43 |
Average Volume (30 Days) | 30,881 |
Short Selling Information
The latest short interest is 34,885, so 0.05% of the outstanding shares have been sold short.
Short Interest | 34,885 |
Short Previous Month | 28,461 |
Short % of Shares Out | 0.05% |
Short % of Float | 0.07% |
Short Ratio (days to cover) | 1.37 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -35.68M |
Pretax Income | -29.14M |
Net Income | -29.16M |
EBITDA | -21.53M |
EBIT | -22.60M |
Earnings Per Share (EPS) | -$0.42 |
Balance Sheet
The company has $81.79 million in cash and $13.28 million in debt, giving a net cash position of $68.51 million or $0.98 per share.
Cash & Cash Equivalents | 81.79M |
Total Debt | 13.28M |
Net Cash | 68.51M |
Net Cash Per Share | $0.98 |
Equity / Book Value | 84.48M |
Book Value Per Share | 1.21 |
Working Capital | 78.65M |
Cash Flow
In the last 12 months, operating cash flow was -$17.96 million and capital expenditures -$6.40 million, giving a free cash flow of -$24.36 million.
Operating Cash Flow | -17.96M |
Capital Expenditures | -6.40M |
Free Cash Flow | -24.36M |
FCF Per Share | -$0.35 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DRTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.20% |
Shareholder Yield | -9.20% |
Earnings Yield | -14.19% |
FCF Yield | -11.85% |
Analyst Forecast
The average price target for DRTS is $11.75, which is 298.31% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.75 |
Price Target Difference | 298.31% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |